Transurethral resection of the prostate (TURP) is a surgical procedure used to treat an enlarged prostate, a condition known as benign prostatic hyperplasia (BPH). This procedure is performed through the urethra, eliminating the need for external incisions.
During a TURP, a specialized instrument called a resectoscope is inserted into the urethra and advanced toward the prostate. The resectoscope consists of a light source, a camera, and a wire loop or cutting device for removing excess prostate tissue. The surgeon carefully removes small portions of the prostate gland, aiming to alleviate urinary symptoms caused by the enlarged prostate.
The procedure is typically performed under general anesthesia or spinal anesthesia and requires hospitalization for a few days. Following the surgery, a catheter may be placed temporarily to help drain urine from the bladder while the prostate heals.
TURP is considered the gold standard treatment for moderate to severe urinary symptoms caused by BPH that do not improve with medication. By removing excess prostate tissue, the procedure aims to improve urine flow, relieve urinary frequency and urgency, decrease residual urine volume, and alleviate symptoms such as weak urinary stream and difficulty starting and stopping urination.
Although TURP is generally safe, like any surgical procedure, it carries some risks, including bleeding, infection, urinary incontinence, retrograde ejaculation, erectile dysfunction, and urethral stricture. It is important for patients to discuss the benefits and risks of TURP with their healthcare provider to make an informed decision about their treatment options for BPH.
